Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sanofi SA Receives Positive Recommendation from European Medicines Agency for New Multiple Sclerosis Pill Aubagio -Reuters


Friday, 22 Mar 2013 08:40am EDT 

Reuters reported that Sanofi SA announced that its new multiple sclerosis pill Aubagio have received positive recommendation from the European Union. 

Company Quote

79.39
-1.089 -1.35%
22 Aug 2014